Primary Site >> Colorectal Cancer
Gene >> SYCE1L
| 1. | |||||||||||
| Journal: | Pharmacology. 2000 Sep;61(3):212-27. | ||||||||||
| Title: | Molecular genetics of cancer susceptibility. | ||||||||||
| Author: | Brockmoller, J|Cascorbi, I|Henning, S|Meisel, C|Roots, I | ||||||||||
| PMID: | 10971208 | ||||||||||
| 2. | |||||||||||
| Journal: | Biochem Pharmacol. 2001 Mar 1;61(5):555-63. | ||||||||||
| Title: | Differential sensitivities of the MRP gene family and gamma-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status. | ||||||||||
| Author: | Lin-Lee, Y C|Tatebe, S|Savaraj, N|Ishikawa, T|Tien Kuo, M | ||||||||||
| PMID: | 11239498 | ||||||||||
| 3. | |||||||||||
| Journal: | Pharm Res. 2001 Aug;18(8):1102-9. | ||||||||||
| Title: | Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. | ||||||||||
| Author: | Cummins, C L|Mangravite, L M|Benet, L Z | ||||||||||
| PMID: | 11587480 | ||||||||||
| 4. | |||||||||||
| Journal: | Pharm Res. 2003 Feb;20(2):324-7. | ||||||||||
| Title: | Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines. | ||||||||||
| Author: | Nakumura, Tsutomu|Sakaeda, Toshiyuki|Ohmoto, Nobuko|Moriya, Yuka|Komoto, Chiho|Shirakawa, Toshiro|Gotoh, Akinobu|Matsuo, Masafumi|Okmura, Katsuhiko | ||||||||||
| PMID: | 12636175 | ||||||||||
| 5. | |||||||||||
| Journal: | Biochem Pharmacol. 2004 Jan 1;67(1):31-9. | ||||||||||
| Title: | Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins. | ||||||||||
| Author: | Cummings, Jeffrey|Zelcer, Noam|Allen, John D|Yao, Denggao|Boyd, Gary|Maliepaard, Mark|Friedberg, Thomas H|Smyth, John F|Jodrell, Duncan I | ||||||||||
| PMID: | 14667926 | ||||||||||
| 6. | |||||||||||
| Journal: | Curr Cancer Drug Targets. 2008 Aug;8(5):414-20. | ||||||||||
| Title: | Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy. | ||||||||||
| Author: | Gradilone, A|Pulcinelli, F M|Lotti, L V|Trifiro, E|Martino, S|Gandini, O|Gianni, W|Frati, L|Agliano, A M|Gazzaniga, P | ||||||||||
| PMID: | 18690847 | ||||||||||
| 7. | |||||||||||
| Journal: | Chem Biol Interact. 2011 May 30;191(1-3):239-49. | ||||||||||
| Title: | Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. | ||||||||||
| Author: | Ebert, Bettina|Kisiela, Michael|Wsol, Vladimir|Maser, Edmund | ||||||||||
| PMID: | 21215737 | ||||||||||
| 8. | |||||||||||
| Journal: | Hepatogastroenterology. 2012 Jun;59(116):1075-8. | ||||||||||
| Title: | Can immunohistochemistry of multidrug-resistant proteins replace the histoculture drug response assay in colorectal adenocarcinomas? | ||||||||||
| Author: | Lee, Ju-Han|Um, Jun-Won|Lee, Ji-Hye|Kim, Seo-Hee|Lee, Eung-Seok|Kim, Young-Sik | ||||||||||
| PMID: | 22580657 | ||||||||||
| 9. | |||||||||||
| Journal: | Mol Pharm. 2012 Sep 4;9(9):2565-76. | ||||||||||
| Title: | Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins. | ||||||||||
| Author: | Herraez, Elisa|Gonzalez-Sanchez, Ester|Vaquero, Javier|Romero, Marta R|Serrano, Maria A|Marin, Jose J G|Briz, Oscar | ||||||||||
| PMID: | 22800197 | ||||||||||
| 10. | |||||||||||
| Journal: | Cell Death Dis. 2013 Apr 25;4:e605. | ||||||||||
| Title: | The Myb-p300-CREB axis modulates intestine homeostasis, radiosensitivity and tumorigenesis. | ||||||||||
| Author: | Sampurno, S|Bijenhof, A|Cheasley, D|Xu, H|Robine, S|Hilton, D|Alexander, W S|Pereira, L|Mantamadiotis, T|Malaterre, J|Ramsay, R G | ||||||||||
| PMID: | 23618903 | ||||||||||
| 11. | |||||||||||
| Journal: | Biomed Pharmacother. 2016 Jul;81:38-47. | ||||||||||
| Title: | Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells. | ||||||||||
| Author: | Semelakova, M|Jendzelovsky, R|Fedorocko, P | ||||||||||
| PMID: | 27261575 | ||||||||||
| 12. | |||||||||||
| Journal: | Anticancer Drugs. 2017 Apr;28(4):410-420. | ||||||||||
| Title: | 2-Deoxy-D-glucose suppresses the migration and reverses the drug resistance of colon cancer cells through ADAM expression regulation. | ||||||||||
| Author: | Park, Ga B|Chung, Yoon H|Kim, Daejin | ||||||||||
| PMID: | 28059830 | ||||||||||
| 13. | |||||||||||
| Journal: | Oncotarget. 2017 May 23;8(21):34617-34629. | ||||||||||
| Title: | Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1. | ||||||||||
| Author: | Herraez, Elisa|Sanchez-Vicente, Laura|Macias, Rocio I R|Briz, Oscar|Marin, Jose J G | ||||||||||
| PMID: | 28423714 | ||||||||||